Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3‐fluorophenmetrazine (3‐FPM)

Separation of positional isomers of nine 2-phenethylamine-derived designer drugs by liquid chromatography-tandem mass spectrometry

(2018) Christina Grumann et al.   Drug Testing and Analysis

Fluorinated phenmetrazine “legal highs” act as substrates for high-affinity monoamine transporters of the SLC6 family

(2018) Felix P. Mayer et al.   NEUROPHARMACOLOGY

Multiple Drug-Toxicity Involving Novel Psychoactive Substances, 3-Fluorophenmetrazine and U-47700

(2017) Kayla N Ellefsen et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Adverse events related to the new psychoactive substance 3-fluorophenmetrazine – results from the Swedish STRIDA project

(2016) Matilda Bäckberg et al.   CLINICAL TOXICOLOGY

Test purchase, synthesis and characterization of 3-fluorophenmetrazine (3-FPM) and differentiation from itsortho- andpara-substituted isomers

(2016) Gavin McLaughlin et al.   Drug Testing and Analysis

3-Fluorophenmetrazine, a fluorinated analogue of phenmetrazine: Studies on in vivo metabolism in rat and human, in vitro metabolism in human CYP isoenzymes and microbial biotransformation in Pseudomonas Putida and wastewater using GC and LC coupled to (HR)-MS techniques

(2016) Marie Mardal et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum

(2010) Ariane Wohlfarth et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY